Posts Tagged: "oncology"

$1.5 billion Celator purchase buoys the financial future of Jazz Pharmaceuticals’ oncology division

Of particular interest in this deal is a drug in Celator’s pipeline is Vyxeos (cytarabine:daunorubicin), an injectable liposomal treatment for blood cancers, especially acute myeloid leukemia (AML). The treatment, which has received a Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for fast-tracked approval, recently achieved positive results in a Phase 3 trial. Patients with high-risk, or secondary, AML who received Vyxeos injections saw a significant increase in overall survival rates, 41.5 percent for Vyxeos-treated patients versus 27.6 percent for other patients in a year’s time.

Blue Ribbon Panel of Advisors Announced for Biden Cancer Moonshot Initiative

Earlier this week the National Cancer Institute (NCI), which is part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will work to inform the scientific direction and goals for Vice President Joe Biden’s National Cancer Moonshot Initiative. “Thanks to advances in science, we are now in a historically unique position to make profound improvements in the way we treat, detect, and prevent cancer,” said NIH Director Francis S. Collins, M.D., Ph.D. He is correct, and here is why.

IBM recent R&D focuses on software solutions for healthcare, energy grid renewables

IBM is involved with the development of medical technologies for fields other than oncology, as is evidenced by the issue of U.S. Patent No. 9064306, which is titled Bidirectional Blood Vessel Segmentation. The method for segmenting blood vessels protected here involves receiving an angiogram frame, processing the angiogram frame by applying a Butterworth bandpass filter to suppress high and low frequency background noise, performing both bottom-up filtering and top-down segmentation of the angiogram frame and repeating that process until the results of the top-down segmentation from consecutive iterations equals or exceeds a threshold value. This process is useful for the analysis of angiogram images captured through cardiac catheterization as it can reduce the amount of feedback noise in those images.

US Oncologists Report Crucial Cancer Drug Shortages

The mantra of the anti-patent community is nearly in unison on the issue of patented drugs. Of course, everyone wants drugs to be developed, but no one wants to pay the exorbitant prices charged for blockbuster, patented drugs. You can add me to that list of individuals who doesn’t like the prices, but at least there is a benefit. Without appropriate financial incentives in place drugs would not be patented, but then again they wouldn’t be developed either. But what is the justification for scarcity and exorbitant prices of old drugs that are off patent?